New insider activity at Viemed Healthcare ( (VMD) ) has taken place on August 14, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viemed Healthcare’s VP of Sales, Jerome Cambre, recently sold 4,880 shares of the company’s stock, amounting to a total transaction value of $35,737.
Recent Updates on VMD stock
Viemed Healthcare’s recent financial disclosures and strategic initiatives have led to a positive outlook on its stock. The company reported a 14.7% increase in net revenues for Q2 2025, driven by robust growth in its core operations, including a 115.1% rise in net income and an 11.5% increase in adjusted EBITDA. Key developments include the acquisition of Lehan Medical Equipment, which supports Viemed’s expansion into maternal health and enhances its respiratory and sleep therapy offerings. This acquisition, along with a successful share repurchase program and increased patient counts, underpins the company’s raised full-year revenue and EBITDA guidance. Despite minor challenges such as a slight decline in gross margins and a slowdown in the staffing business, Viemed’s strategic growth initiatives and strong financial performance have bolstered its market position, leading to positive analyst sentiment and a raised price target.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.
Viemed Healthcare’s strong financial performance and positive earnings call sentiment are the most significant factors driving the score. The company’s strategic acquisitions and share repurchase program further bolster its market position. However, challenges in cash flow management and valuation concerns slightly temper the overall outlook.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
YTD Price Performance: -9.84%
Average Trading Volume: 232,484
Technical Sentiment Signal: Buy
Current Market Cap: $288.6M